z-logo
Premium
Polymorphous low grade adenocarcinoma
Author(s) -
Castle James T.,
Thompson Lester D. R.,
Frommelt R. Allen,
Wenig Bruce M.,
Kessler Harvey P.
Publication year - 1999
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/(sici)1097-0142(19990715)86:2<207::aid-cncr4>3.0.co;2-q
Subject(s) - medicine , adenoid cystic carcinoma , adenoid , salivary gland , pathology , adjuvant therapy , adenocarcinoma , neoplasm , immunohistochemistry , cancer , carcinoma
BACKGROUND Polymorphous low grade adenocarcinomas (PLGA) are minor salivary gland neoplasms with a predilection for intraoral sites. METHODS One hundred sixty‐four cases of PLGA diagnosed between 1970–1994 were retrieved from the files of the Armed Forces Institute of Pathology, Washington, DC. Histologic features were reviewed, immunohistochemical studies and prognostic markers were performed, and patient follow‐up was obtained. The data were analyzed statistically. RESULTS The patients included 109 women and 55 men, ages 23–94 years (average, 57.6 years). The patients usually presented clinically with a palatal mass that ranged in size from 0.4–6 cm (average, 2.2 cm). The tumors were infiltrative and characterized by a polymorphous growth pattern, with individual tumors demonstrating multiple patterns, including solid, ductotubular, cribriform, trabecular, and single file growth. Neurotropism was identified frequently. The neoplastic cells were isomorphic with vesicular nuclei. Mitotic activity was inconspicuous. At an average of 115.4 months after presentation, approximately 97.6% of all patients were either alive or had died without evidence of recurrent disease after treatment with surgical excision only. Four patients had evidence of disease at last follow‐up; three had died with evidence of tumor, and one patient was alive with tumor. CONCLUSIONS PLGA is a neoplasm of minor salivary gland origin that must be separated from adenoid cystic carcinoma and benign mixed tumor for therapeutic and prognostic considerations. Conservative but complete surgical excision is the treatment of choice for these slow‐growing tumors with a low proliferation index; adjuvant therapy does not appear to alter the prognosis. Cancer 1999;86:207–19. © 1999 American Cancer Society.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here